Humana Says Rising Rx Prices Will Hurt Earnings
Humana lowered its earnings estimate for the year, attributing the reduction to rising medication costs and an underestimate of how many Medicare beneficiaries with serious health problems would enroll in its plans. The insurer is the second-largest seller of Medicare drug benefit plans.
- "Humana Cuts Forecast as Prescription Costs Expand" (Bloomberg/Los Angeles Times, 3/13).